Inventor · disambiguated record
Herriot Tabuteau
Also filed as: TABUTEAU HERRIOT
407 granted patents·188 pending applications·23,265 citations·filing 2012–2025
99Inventor score
Files withANTECIP BIOVENTURES II LLC374AXSOME THERAPEUTICS INC191AXSOME MALTA LTD16TABUTEAU HERRIOT10ANTECIP BIOVENTURES II LLP3
Top patents by PatentIndex Score
595 records- 0199US12485176B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2025·Granted Dec 2, 2025·2 cites·17 claims
- 0299US12478622B2Bupropion dosage forms with reduced food and alcohol dosing effectsANTECIP BIOVENTURES II LLC·Filed 2025·Granted Nov 25, 2025·2 cites·26 claims
- 0399US12478678B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2025·Granted Nov 25, 2025·1 cites·20 claims
- 0499US12472256B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2025·Granted Nov 18, 2025·1 cites·20 claims
- 0599US12472174B2Bupropion dosage forms with reduced food and alcohol dosing effectsANTECIP BIOVENTURES II LLC·Filed 2025·Granted Nov 18, 2025·2 cites·24 claims
- 0699US12472258B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2025·Granted Nov 18, 2025·1 cites·20 claims
- 0799US12472257B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2025·Granted Nov 18, 2025·1 cites·20 claims
- 0899US12447155B2Use of reboxetine to treat narcolepsyAXSOME THERAPEUTICS INC·Filed 2025·Granted Oct 21, 2025·1 cites·16 claims
- 0999US12433884B2Compounds and combinations thereof for treating neurological and psychiatric conditionsANTECIP BIOVENTURES II LLC·Filed 2025·Granted Oct 7, 2025·3 cites·21 claims
- 1099US12364674B2Compounds and combinations thereof for treating neurological and psychiatric conditionsANTECIP BIOVENTURES II LLC·Filed 2023·Granted Jul 22, 2025·7 cites·25 claims
- 1199US12310961B2Bupropion dosage forms with reduced food and alcohol dosing effectsANTECIP BIOVENTURES II LLC·Filed 2023·Granted May 27, 2025·11 cites·13 claims
- 1299US12263161B2Bupropion dosage forms with reduced food and alcohol dosing effectsANTECIP BIOVENTURES II LLC·Filed 2024·Granted Apr 1, 2025·16 cites·22 claims
- 1399US12246023B2Use of reboxetine to treat narcolepsyAXSOME THERAPEUTICS INC·Filed 2023·Granted Mar 11, 2025·10 cites·13 claims
- 1499US12239642B2Bupropion dosage forms with reduced food and alcohol dosing effectsANTECIP BIOVENTURES II LLC·Filed 2024·Granted Mar 4, 2025·15 cites·22 claims
- 1599US12194006B2Bupropion as a modulator of drug activityANTECIP BIOVENTURES II LLC·Filed 2021·Granted Jan 14, 2025·16 cites·22 claims
- 1699US12194005B2Compounds and combinations thereof for treating neurological and psychiatric conditionsANTECIP BIOVENTURES II LLC·Filed 2024·Granted Jan 14, 2025·19 cites·19 claims
- 1799US12194036B2Combination of dextromethorphan and bupropion for treating depressionANTECIP BIOVENTURES II LLC·Filed 2023·Granted Jan 14, 2025·20 cites·18 claims
- 1899US12156914B2Pharmaceutical compositions comprising bupropion and cysteineAXSOME THERAPEUTICS INC·Filed 2023·Granted Dec 3, 2024·23 cites·17 claims
- 1999US12146889B1Compounds and combinations thereof for treating neurological and psychiatric conditionsANTECIP BIOVENTURES II LLC·Filed 2023·Granted Nov 19, 2024·16 cites·16 claims
- 2099US12138260B2Compounds and combinations thereof for treating neurological and psychiatric conditionsANTECIP BIOVENTURES II LLC·Filed 2023·Granted Nov 12, 2024·16 cites·20 claims
- 2199US12128052B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2023·Granted Oct 29, 2024·13 cites·18 claims
- 2299US12109178B2Bupropion as a modulator of drug activityANTECIP BIOVENTURES II LLC·Filed 2022·Granted Oct 8, 2024·20 cites·18 claims
- 2399US12042473B2Compounds and combinations thereof for treating neurological and psychiatric conditionsANTECIP BIOVENTURES II LLC·Filed 2023·Granted Jul 23, 2024·21 cites·9 claims
- 2499US12036191B1Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphanANTECIP BIOVENTURES II LLC·Filed 2023·Granted Jul 16, 2024·19 cites·30 claims
- 2599US12005118B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2023·Granted Jun 11, 2024·13 cites·28 claims
- 2699US11986444B2Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphanANTECIP BIOVENTURES II LLC·Filed 2023·Granted May 21, 2024·22 cites·28 claims
- 2799US11969421B2Bupropion as a modulator of drug activityANTECIP BIOVENTURES II LLC·Filed 2022·Granted Apr 30, 2024·22 cites·29 claims
- 2899US11944683B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2023·Granted Apr 2, 2024·17 cites·30 claims
- 2999US11925636B2Bupropion dosage forms with reduced food and alcohol dosing effectsANTECIP BIOVENTURES II LLC·Filed 2023·Granted Mar 12, 2024·28 cites·22 claims
- 3099US11896563B2Bupropion and dextromethorphan for reduction of suicide risk in depression patientsANTECIP BIOVENTURES II LLC·Filed 2023·Granted Feb 13, 2024·30 cites·17 claims
- 3199US11883373B1Treatment of depression in certain patient populationsANTECIP BIOVENTURES II LLC·Filed 2023·Granted Jan 30, 2024·30 cites·19 claims
- 3299US11865117B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2022·Granted Jan 9, 2024·22 cites·24 claims
- 3399US11844797B1Combination of dextromethorphan and bupropion for treating depressionANTECIP BIOVENTURES II LLC·Filed 2023·Granted Dec 19, 2023·31 cites·14 claims
- 3499US11839612B1Compounds and combinations thereof for treating neurological and psychiatric conditionsANTECIP BIOVENTURES II LLC·Filed 2023·Granted Dec 12, 2023·31 cites·18 claims
- 3599US11826354B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2023·Granted Nov 28, 2023·17 cites·25 claims
- 3699US11826370B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2022·Granted Nov 28, 2023·17 cites·14 claims
- 3799US11779579B2Bupropion as a modulator of drug activityANTECIP BIOVENTURES II LLC·Filed 2022·Granted Oct 10, 2023·34 cites·22 claims
- 3899US11759522B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2022·Granted Sep 19, 2023·23 cites·20 claims
- 3999US11752144B1Compounds and combinations thereof for treating neurological and psychiatric conditionsANTECIP BIOVENTURES II LLC·Filed 2023·Granted Sep 12, 2023·36 cites·14 claims
- 4099US11738085B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2022·Granted Aug 29, 2023·23 cites·29 claims
- 4199US11730706B1Treatment of depression in certain patient populationsANTECIP BIOVENTURES II LLC·Filed 2023·Granted Aug 22, 2023·39 cites·20 claims
- 4299US11717518B1Bupropion dosage forms with reduced food and alcohol dosing effectsANTECIP BIOVENTURES II LLC·Filed 2023·Granted Aug 8, 2023·34 cites·23 claims
- 4399US11712441B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2022·Granted Aug 1, 2023·25 cites·18 claims
- 4499US11660273B2Dosage forms and methods for enantiomerically enriched or pure bupropionAXSOME THERAPEUTICS INC·Filed 2022·Granted May 30, 2023·39 cites·19 claims
- 4599US11660274B2Dosage forms and methods for enantiomerically enriched or pure bupropionAXSOME THERAPEUTICS INC·Filed 2022·Granted May 30, 2023·39 cites·19 claims
- 4699US11628173B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2022·Granted Apr 18, 2023·26 cites·19 claims
- 4799US11628149B2Bupropion as a modulator of drug activityANTECIP BIOVENTURES II LLC·Filed 2022·Granted Apr 18, 2023·40 cites·19 claims
- 4899US11617747B2Bupropion as a modulator of drug activityANTECIP BIOVENTURES II LLC·Filed 2021·Granted Apr 4, 2023·40 cites·15 claims
- 4999US11617728B2Bupropion as a modulator of drug activityANTECIP BIOVENTURES II LLC·Filed 2022·Granted Apr 4, 2023·40 cites·21 claims
- 5099US11617755B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2022·Granted Apr 4, 2023·24 cites·27 claims
Showing the top 50 of 595 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Herriot Tabuteau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →